IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 520 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2766    
    Printed91    
    Emailed3    
    PDF Downloaded381    
    Comments [Add]    

Recommend this journal

 

 REVIEW ARTICLE
Year : 1998  |  Volume : 30  |  Issue : 5  |  Page : 277-298

The NMDA receptor in epilepsy


Correspondence Address:
Manocha Anshu


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

N-methyl-D-aspartate(NMDA) receptors have been the target of a large number of studies, and the field of research is still rapidly growing. Many in vivo and in vitro studies support the hypothesis that NMDA receptors contribute to the development and expression of epilepsy and play a pivotal role in induction of synaptic plasticity i.e. long-term potentiation (LTP). Decreasing glutamatergic neurotransmission pro-vides rational therapeutic approaches to epilepsy. Potent anticonvulsant effects are seen with the acute administration of NMDA antagonists in a wide range of animal models. NMDA receptors are important potential targets for the development of antiepileptic drugs. However, the early optimism regarding competitive NMDA recognition site antagonists as antiepileptic drug candidates has been tempered by the recognition that such antagonists have significant toxicities. Several other approaches to NMDA receptor blockade appear promising, including competitive antagonism at the glycine site and low-affinity channel blockade. In addition, there is interest in NMDA-associated polyamine-and redox sites but clearly further work is required to address this issue. Interestingly, molecular biology studies of NMDA receptor have revealed multiplicity in this receptor subtypes and NMDA receptor subunit, NR1 and NR2 represent heterogeneity in this receptor. Certain classes of NMDA receptor antagonists are selective for specific subunit combinations.This is an area with promising scope in future for pharmacological exploitation, for instance, designing antagonists that are selective for subunit combinations that might show an increased expression during epileptogenesis. There are, however, many important questions that remain only partly answered and probably many more surprises ahead.






[PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow